Shares of Sonic Healthcare Ltd. Sponsored ADR (OTCMKTS:SKHHY – Get Free Report) saw unusually-high trading volume on Friday . Approximately 49,219 shares changed hands during trading, a decline of 46% from the previous session’s volume of 91,234 shares.The stock last traded at $14.0264 and had previously closed at $14.02.
Analyst Ratings Changes
Separately, Citigroup downgraded shares of Sonic Healthcare from a “hold” rating to a “strong sell” rating in a research report on Monday, January 26th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has a consensus rating of “Sell”.
Get Our Latest Research Report on Sonic Healthcare
Sonic Healthcare Stock Performance
Sonic Healthcare Company Profile
Sonic Healthcare (OTCMKTS:SKHHY) is a global provider of medical diagnostics services, specializing in pathology and radiology. Established in 1987 and headquartered in Sydney, Australia, the company has grown into one of the largest laboratory networks in the world. Its ordinary shares trade on the Australian Securities Exchange, and its American Depositary Receipts trade over the counter under the symbol SKHHY.
The company offers a broad range of clinical pathology services, including anatomic pathology, clinical chemistry, hematology, microbiology and molecular diagnostics.
See Also
Receive News & Ratings for Sonic Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sonic Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.
